Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase

Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase

US Patent 10975167 · Granted Apr 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers and methods of use for radiation-induced lung injury2023
Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies2022
Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies2021
Method of treating one or more symptoms of pulmonary fibrosis by administering i2021
Biomarkers for assessing idiopathic pulmonary fibrosis2021
Methods for characterizing cancer2020
Compositions and methods for treating and preventing lung injury2019
Biomarkers for assessing idiopathic pulmonary fibrosis2018
Use of opioid antagonists2017
Use of opioid antagonists to attenuate endothelial cell proliferation and migrat2017
Use of opioid antagonists to attenuate endothelial cell proliferation and migrat2017
Use of opioid antagonists to attenuate endothelial cell proliferation and migrat2017